Remove 2025 Remove Clinical Practice Remove Community Remove Individual
article thumbnail

Rheumatology Board Meeting Summary | Spring 2025

ABIM

Salahuddin Kazi, MD, Chair, Rheumatology Board The Rheumatology Board , which meets twice a year and is responsible for oversight of policy and assessment in the specialty, held its spring meeting on March 11, 2025. Chrostowski, DNP, APRN, ANP-C , Maryah Mansoor, MD , and Philip Seo, MD , whose terms on the Specialty Board end June 30, 2025.

article thumbnail

Two “Unresolvable” Prescribing/Dispensing Red Flags Unfurled

FDA Law Blog

Attorneys Office, Northern District of Illinois, April 21, 2025, quoted here. Our reader informed us of two additional prescribing/dispensing red flags that DEA has alleged are unresolvable that he wanted to share with the pharmacy community. 72,694, 72,703 (Dec. Deborah Dowell et al., 1, Recommendation 3. Recommendation 1.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Infectious Disease Board Meeting Summary | Spring 2025

ABIM

Erin Bonura, MD, Chair, ABIM Infectious Disease Board The Infectious Disease Board , which meets twice a year and is responsible for oversight of ABIM policy and assessment in the specialty, held its spring meeting on March 25, 2025. JD , whose terms on the Specialty Board end June 30, 2025.

article thumbnail

Hematology Board Meeting Summary | Spring 2025

ABIM

Gertz, MD, MACP, Chair, ABIM Hematology Board The Hematology Board , which meets twice a year and is responsible for oversight of ABIM policy and assessment in the specialty, held its spring meeting on May 2, 2025. Most (49.5%) are in single-specialty group practice or multi-specialty group practice (38%).

article thumbnail

Lung cancer screening in primary care: more pragmatic research needed

Common Sense Family Doctor

Despite private and public insurance plans fully covering lung cancer screening in the United States, only 10% to 30% of eligible individuals in were receiving it in a recent state-by-state survey. to 3.33, indicating that even the most pragmatic studies fell well short of simulating conditions in community settings.

article thumbnail

What can we learn from simulations? Amber Barnato

GeriPal

Alex: We are delighted to welcome Amber Barnato, who’s a palliative care physician and health service researcher, and she’s director of the Dartmouth Institute for Health Policy and Clinical Practice. And so she was able to validate that their nonverbal communication was very different within an individual physician.

article thumbnail

PC for Patients with Substance Use Disorder: Janet Ho, Sach Kale, Julie Childers

GeriPal

Substance use disorder is one of those complex issues in which clinical practice is changing rapidly. And I’m wondering from a practical standpoint, when you think about pain management in those with a history of substance use disorder who have substance use disorder active like is buprenorphine like your go to drug right now?